SANDHYA MUDUMBI

Allopathic & Osteopathic Physicians|Internal Medicine|Hospice and Palliative Medicine NASHVILLE, TN NPI 1902249089

General Payments — all program years on this page

$1,411.12

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $461.47 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $461.4719

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $215.072
2022 $285.275
2023 $449.3118
2024 $461.4719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087145476 Novartis Pharmaceuticals Corporation $13.09 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087145498 Novartis Pharmaceuticals Corporation $25.76 11/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093911078 Alexion Pharmaceuticals, Inc. $16.05 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104234329 AstraZeneca Pharmaceuticals LP $15.01 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104277315 AstraZeneca Pharmaceuticals LP $26.01 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105077235 ABBVIE INC. $23.54 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105077237 ABBVIE INC. $23.85 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113853060 PUMA BIOTECHNOLOGY, INC. $15.23 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114119698 Regeneron Healthcare Solutions, Inc. $37.96 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114119700 Regeneron Healthcare Solutions, Inc. $27.14 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120220399 EMD Serono, Inc. $24.97 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137937283 TAIHO ONCOLOGY, INC. $14.33 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139336374 Astellas Pharma US Inc $23.36 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141726227 Merck Sharp & Dohme LLC $28.80 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141933951 Merck Sharp & Dohme LLC $22.25 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143486033 Aveo Pharmaceuticals, Inc. $38.99 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143486039 Aveo Pharmaceuticals, Inc. $41.30 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145874335 Deciphera Pharmaceuticals Inc. $26.90 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148894199 Sumitomo Pharma America, Inc. $16.93 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.